Detalhe da pesquisa
1.
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions.
Blood
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662991
2.
177Lu-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity 111In-octreotide.
Eur J Nucl Med Mol Imaging
; 37(10): 1869-75, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20445977